197 related articles for article (PubMed ID: 18849497)
1. Preventive but not late amiloride therapy reduces morbidity and mortality of lung disease in betaENaC-overexpressing mice.
Zhou Z; Treis D; Schubert SC; Harm M; Schatterny J; Hirtz S; Duerr J; Boucher RC; Mall MA
Am J Respir Crit Care Med; 2008 Dec; 178(12):1245-56. PubMed ID: 18849497
[TBL] [Abstract][Full Text] [Related]
2. Role of the amiloride-sensitive epithelial Na+ channel in the pathogenesis and as a therapeutic target for cystic fibrosis lung disease.
Mall MA
Exp Physiol; 2009 Feb; 94(2):171-4. PubMed ID: 19060118
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of second generation amiloride analogs as therapy for cystic fibrosis lung disease.
Hirsh AJ; Sabater JR; Zamurs A; Smith RT; Paradiso AM; Hopkins S; Abraham WM; Boucher RC
J Pharmacol Exp Ther; 2004 Dec; 311(3):929-38. PubMed ID: 15273255
[TBL] [Abstract][Full Text] [Related]
4. The ENaC-overexpressing mouse as a model of cystic fibrosis lung disease.
Zhou Z; Duerr J; Johannesson B; Schubert SC; Treis D; Harm M; Graeber SY; Dalpke A; Schultz C; Mall MA
J Cyst Fibros; 2011 Jun; 10 Suppl 2():S172-82. PubMed ID: 21658636
[TBL] [Abstract][Full Text] [Related]
5. Early cystic fibrosis lung disease: Role of airway surface dehydration and lessons from preventive rehydration therapies in mice.
Mall MA; Graeber SY; Stahl M; Zhou-Suckow Z
Int J Biochem Cell Biol; 2014 Jul; 52():174-9. PubMed ID: 24561284
[TBL] [Abstract][Full Text] [Related]
6. Lack of neutrophil elastase reduces inflammation, mucus hypersecretion, and emphysema, but not mucus obstruction, in mice with cystic fibrosis-like lung disease.
Gehrig S; Duerr J; Weitnauer M; Wagner CJ; Graeber SY; Schatterny J; Hirtz S; Belaaouaj A; Dalpke AH; Schultz C; Mall MA
Am J Respir Crit Care Med; 2014 May; 189(9):1082-92. PubMed ID: 24678594
[TBL] [Abstract][Full Text] [Related]
7. Increased airway epithelial Na+ absorption produces cystic fibrosis-like lung disease in mice.
Mall M; Grubb BR; Harkema JR; O'Neal WK; Boucher RC
Nat Med; 2004 May; 10(5):487-93. PubMed ID: 15077107
[TBL] [Abstract][Full Text] [Related]
8. Loss of Cftr function exacerbates the phenotype of Na(+) hyperabsorption in murine airways.
Livraghi-Butrico A; Kelly EJ; Wilkinson KJ; Rogers TD; Gilmore RC; Harkema JR; Randell SH; Boucher RC; O'Neal WK; Grubb BR
Am J Physiol Lung Cell Mol Physiol; 2013 Apr; 304(7):L469-80. PubMed ID: 23377346
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Inhibition of Cathepsin S Reduces Inflammation and Mucus Plugging in Adult
Brown R; Small DM; Doherty DF; Holsinger L; Booth R; Williams R; Ingram RJ; Elborn JS; Mall MA; Taggart CC; Weldon S
Mediators Inflamm; 2021; 2021():6682657. PubMed ID: 33828414
[TBL] [Abstract][Full Text] [Related]
10. Impaired mucus clearance exacerbates allergen-induced type 2 airway inflammation in juvenile mice.
Fritzsching B; Hagner M; Dai L; Christochowitz S; Agrawal R; van Bodegom C; Schmidt S; Schatterny J; Hirtz S; Brown R; Goritzka M; Duerr J; Zhou-Suckow Z; Mall MA
J Allergy Clin Immunol; 2017 Jul; 140(1):190-203.e5. PubMed ID: 27865862
[TBL] [Abstract][Full Text] [Related]
11. Pharmacological properties of N-(3,5-diamino-6-chloropyrazine-2-carbonyl)-N'-4-[4-(2,3-dihydroxypropoxy)phenyl]butyl-guanidine methanesulfonate (552-02), a novel epithelial sodium channel blocker with potential clinical efficacy for cystic fibrosis lung disease.
Hirsh AJ; Zhang J; Zamurs A; Fleegle J; Thelin WR; Caldwell RA; Sabater JR; Abraham WM; Donowitz M; Cha B; Johnson KB; St George JA; Johnson MR; Boucher RC
J Pharmacol Exp Ther; 2008 Apr; 325(1):77-88. PubMed ID: 18218832
[TBL] [Abstract][Full Text] [Related]
12. Neutrophil extracellular traps are present in the airways of ENaC-overexpressing mice with cystic fibrosis-like lung disease.
Tucker SL; Sarr D; Rada B
BMC Immunol; 2021 Jan; 22(1):7. PubMed ID: 33478382
[TBL] [Abstract][Full Text] [Related]
13. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
Mall MA
Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
[TBL] [Abstract][Full Text] [Related]
14. Allergic airway inflammation induces a pro-secretory epithelial ion transport phenotype in mice.
Anagnostopoulou P; Dai L; Schatterny J; Hirtz S; Duerr J; Mall MA
Eur Respir J; 2010 Dec; 36(6):1436-47. PubMed ID: 20413543
[TBL] [Abstract][Full Text] [Related]
15. Airway surface liquid volume regulation determines different airway phenotypes in liddle compared with betaENaC-overexpressing mice.
Mall MA; Button B; Johannesson B; Zhou Z; Livraghi A; Caldwell RA; Schubert SC; Schultz C; O'Neal WK; Pradervand S; Hummler E; Rossier BC; Grubb BR; Boucher RC
J Biol Chem; 2010 Aug; 285(35):26945-26955. PubMed ID: 20566636
[TBL] [Abstract][Full Text] [Related]
16. Acute and long-term amiloride inhalation in cystic fibrosis lung disease. A rational approach to cystic fibrosis therapy.
App EM; King M; Helfesrieder R; Köhler D; Matthys H
Am Rev Respir Dis; 1990 Mar; 141(3):605-12. PubMed ID: 2310093
[TBL] [Abstract][Full Text] [Related]
17. Targeting of cathepsin S reduces cystic fibrosis-like lung disease.
Small DM; Brown RR; Doherty DF; Abladey A; Zhou-Suckow Z; Delaney RJ; Kerrigan L; Dougan CM; Borensztajn KS; Holsinger L; Booth R; Scott CJ; López-Campos G; Elborn JS; Mall MA; Weldon S; Taggart CC
Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30655278
[TBL] [Abstract][Full Text] [Related]
18. Hypertonic saline is effective in the prevention and treatment of mucus obstruction, but not airway inflammation, in mice with chronic obstructive lung disease.
Graeber SY; Zhou-Suckow Z; Schatterny J; Hirtz S; Boucher RC; Mall MA
Am J Respir Cell Mol Biol; 2013 Sep; 49(3):410-7. PubMed ID: 23590312
[TBL] [Abstract][Full Text] [Related]
19. Effective silencing of ENaC by siRNA delivered with epithelial-targeted nanocomplexes in human cystic fibrosis cells and in mouse lung.
Tagalakis AD; Munye MM; Ivanova R; Chen H; Smith CM; Aldossary AM; Rosa LZ; Moulding D; Barnes JL; Kafetzis KN; Jones SA; Baines DL; Moss GWJ; O'Callaghan C; McAnulty RJ; Hart SL
Thorax; 2018 Sep; 73(9):847-856. PubMed ID: 29748250
[TBL] [Abstract][Full Text] [Related]
20. Development of chronic bronchitis and emphysema in beta-epithelial Na+ channel-overexpressing mice.
Mall MA; Harkema JR; Trojanek JB; Treis D; Livraghi A; Schubert S; Zhou Z; Kreda SM; Tilley SL; Hudson EJ; O'Neal WK; Boucher RC
Am J Respir Crit Care Med; 2008 Apr; 177(7):730-42. PubMed ID: 18079494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
